News

Daniel Drucker, a pioneer in GLP-1 receptor–agonist research, discusses the history of the drugs, their wide-ranging benefits, and how they might benefit patients with cancer. On April 28, 2005, the ...
Renowned scientist Douglas Hanahan, PhD, discusses the legacy of The Hallmarks of Cancer, the challenge of adaptive resistance, and how insights into the tumor microenvironment and cancer neuroscience ...
A high-resolution map of how protein organization inside the cell provides a platform for interrogating the way cancer mutations disrupt entire protein assemblies—not just individual genes. By ...
Gretchen M. Alicea; Payal Patel; Marie E. Portuallo; Mitchell E. Fane; Meihan Wei; Yash Chhabra; Agrani Dixit; Alexis E. Carey; Vania Wang; Murilo R. Rocha; Reeti ...
Publishing in July 2025 to coincide with the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, the series will continue through December 2025! Technological ...